Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · see citing works

Cross-talk between <i>Akkermansia muciniphila</i> and intestinal epithelium controls diet-induced obesity

Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · see citing works

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1× · see citing works

A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility

Desai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., Pudlo, N. A., Kitamoto, S., Terrapon, N., Muller, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.043 · Cited by 2,805 · see citing works

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22

Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614 · see citing works

Alterations of the human gut microbiome in liver cirrhosis

Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177 · see citing works

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067 · cited 2× · see citing works

An increase in the <i>Akkermansia</i> spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550 · see citing works

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482 · see citing works

Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria

Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · see citing works

Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity

Schirmer, M., Smeekens, S. P., Vlamakis, H. C., Jaeger, M., Oosting, M., Franzosa, E. A., ter Horst, R., Jansen, T., Jacobs, L., Bonder, M. J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.020 · Cited by 1,159 · see citing works

Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice

Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Van Holle, A., François, P., de Vos, W. M., et al. (2011) · Diabetes · doi:10.2337/db11-0227 · Cited by 1,076 · see citing works

Aryl hydrocarbon receptor ligands in cancer: friend and foe

Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3846 · Cited by 889 · see citing works

Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women

Santacruz, A., Collado, M. C., García-Valdés, L., Segura, M. T., Martín-Lagos, J. A., Anjos, T., Martí-Romero, M., Lopez, R. M., Florido, J., Campoy, C., et al. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510000176 · Cited by 868 · see citing works

Intestinal microbiota in patients with nonalcoholic fatty liver disease

Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · see citing works

The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal Tract

Derrien, M., Collado, M. C., Amor, K. B., Salminen, S., & de Vos, W. M. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01226-07 · Cited by 659 · see citing works

Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract

Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T. T., Pallone, F., & Monteleone, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.007 · Cited by 656 · see citing works

Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome

Natividad, J. M., Agus, A., Planchais, J., Lamas, B., Jarry, A. C., Martin, R., Michel, M.-L., Chong-Nguyen, C., Roussel, R., Straube, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.001 · Cited by 642 · see citing works

Recovery of ethanol-induced <i>Akkermansia muciniphila</i> depletion ameliorates alcoholic liver disease

Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313432 · Cited by 618 · see citing works

AhR signaling pathways and regulatory functions

Larigot, L., Juricek, L., Dairou, J., & Coumoul, X. (2018) · Biochimie Open · doi:10.1016/j.biopen.2018.05.001 · Cited by 563 · see citing works

Aryl hydrocarbon receptor and intestinal immunity

Lamas, B., Natividad, J. M., & Sokol, H. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0019-2 · Cited by 530 · see citing works

Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse

Hansen, C. H. F., Krych, Ł., Nielsen, D. S., Vogensen, F. K., Hansen, L. H., Sørensen, S. J., Buschard, K., & Hansen, A. K. (2012) · Diabetologia · doi:10.1007/s00125-012-2564-7 · Cited by 496 · see citing works

Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials

Ruiz‐Ojeda, F. J., Plaza‐Díaz, J., Sáez‐Lara, M. J., & Gil, Á. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy037 · Cited by 428 · see citing works

Metformin: Mechanisms in Human Obesity and Weight Loss

Yerevanian, A., & Soukas, A. A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00335-3 · Cited by 414 · see citing works

Regulation of Obesity-Related Insulin Resistance with Gut Anti-inflammatory Agents

Luck, H., Tsai, S. J., Chung, J., Clemente‐Casares, X., Ghazarian, M., Revelo, X. S., Lei, H., Luk, C. T., Shi, S. Y., Surendra, A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.001 · Cited by 372 · see citing works

Sweeteners as food additives in the XXI century: A review of what is known, and what is to come

Carocho, M., Morales, P., & Ferreira, I. C. F. R. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.06.046 · Cited by 317 · see citing works

Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies

Zhou, K. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.03.045 · Cited by 305 · see citing works

Nonnutritive Sweeteners: Current Use and Health Perspectives

Gardner, C. D., Wylie‐Rosett, J., Gidding, S. S., Steffen, L. M., Johnson, R. K., Reader, D., & Lichtenstein, A. H. (2012) · Circulation · doi:10.1161/cir.0b013e31825c42ee · Cited by 300 · see citing works

Persistent Organic Pollutants Modify Gut Microbiota–Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation

Zhang, L., Nichols, R. G., Correll, J. B., Murray, I. A., Tanaka, N., Smith, P. B. W., Hubbard, T. D., Sebastian, A., Albert, I. U., Hatzakis, E., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1409055 · Cited by 299 · see citing works

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention

Gottwald‐Hostalek, U., Gwilt, M., & Hildemann, S. K. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278 · see citing works

Sucralose metabolism and pharmacokinetics in man

Roberts, A. S., Renwick, A. G. C., Sims, J., & Snodin, D. J. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00026-0 · Cited by 266 · see citing works

Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice

Bian, X., Chi, L., Gao, B., Tu, P., Ru, H., & Lu, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00487 · Cited by 258 · see citing works

Nonnutritive Sweeteners: Current Use and Health Perspectives

Gardner, C., Wylie-Rosett, J., Gidding, S. S., Steffen, L. M., Johnson, R. K., Reader, D., Lichtenstein, A. H., & on behalf of the American Heart Association Nutrition Committee of the Council on Nutrition, P. A. A. M. (2012) · Diabetes Care · doi:10.2337/dc12-9002 · Cited by 229 · see citing works

Saccharin induced liver inflammation in mice by altering the gut microbiota and its metabolic functions

Bian, X., Tu, P., Chi, L., Gao, B., Ru, H., & Lü, K. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.045 · Cited by 224 · see citing works

Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats

Kleessen, B., Hartmann, L., & Blaut, M. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2002827 · Cited by 221 · see citing works

AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice

Goettel, J. A., Gandhi, R., Kenison, J. E., Yeste, A., Murugaiyan, G., Sambanthamoorthy, S., Griffith, A. E., Patel, B., Shouval, D. S., Weiner, H. L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.082 · Cited by 190 · see citing works

Scientific Opinion on the safety of steviol glycosides for the proposed uses as a food additive

(ANS), E. P. O. F. A. A. N. S. A. T. F. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1537 · Cited by 167 · see citing works

Indole-3-Pyruvic Acid, an Aryl Hydrocarbon Receptor Activator, Suppresses Experimental Colitis in Mice

Aoki, R., AOKI-YOSHIDA, A., Suzuki, C., & Takayama, Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701734 · Cited by 165 · see citing works

Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism

Korecka, A., Dona, A. C., Lahiri, S., Tett, A., Al‐Asmakh, M., Braniste, V., D’Arienzo, R., Abbaspour, A., Reichardt, N., Fujii‐Kuriyama, Y., et al. (2016) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2016.14 · Cited by 161 · see citing works

LC–MS/MS-Based Quantification of Kynurenine Metabolites, Tryptophan, Monoamines and Neopterin in Plasma, Cerebrospinal Fluid and Brain

Fuertig, R., Ceci, A., Camus, S. M. J., Bézard, E., Luippold, A. H., & Hengerer, B. (2016) · Bioanalysis · doi:10.4155/bio-2016-0111 · Cited by 160 · see citing works

Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota

Alvarado, D. M., Chen, B., Iticovici, M. S., Thaker, A. I., Dai, N., VanDussen, K. L., Shaikh, N., Lim, C. K., Guillemin, G. J., Tarr, P. I., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.013 · Cited by 156 · see citing works

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

Prendergast, G. C., Chang, M. Y., Mandik‐Nayak, L., Metz, R. A., & Muller, A. J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656072 · Cited by 96 · see citing works

Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice

Zhang, L., Hatzakis, E., Nichols, R. G., Hao, R., Correll, J. B., Smith, P. B. W., Chiaro, C. R., Perdew, G. H., & Patterson, A. D. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b01389 · Cited by 88 · see citing works

The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes

Donnelly, L. A., Doney, A. S. F., Hattersley, A. T., Morris, A. D., & Pearson, E. R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01755.x · Cited by 88 · see citing works

Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer

Engevik, M. A., Engevik, A. C., Engevik, K. A., Auchtung, J. M., Chang‐Graham, A. L., Ruan, W. H., Luna, R. A., Hyser, J. M., Spinler, J. K., & Versalovic, J. A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00634 · Cited by 85 · see citing works

The aryl hydrocarbon receptor in inflammatory bowel disease

Monteleone, I., MacDonald, T. T., Pallone, F., & Monteleone, G. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328352ad69 · Cited by 83 · see citing works

An Improved Method for Determining Medium‐ and Long‐Chain FAMEs Using Gas Chromatography

Xu, Z., Harvey, K. A., Pavlina, T. M., Dutot, G., Zaloga, G. P., & Siddiqui, R. A. (2010) · Lipids · doi:10.1007/s11745-009-3382-7 · Cited by 77 · see citing works

Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis

Demehri, F. R., Frykman, P. K., Cheng, Z., Ruan, C., Wester, T., Nordenskjöld, A., Kawaguchi, A. L., Hui, T., Granström, A. L., Funari, V., et al. (2015) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.10.012 · Cited by 77 · see citing works

Artificial Sweeteners: A Systematic Review and Primer for Gastroenterologists

Spencer, M. A., Gupta, A. K., Dam, L. V., Shannon, C., Menees, S. B., & Chey, W. D. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15206 · Cited by 69 · see citing works

Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis

Murray, I. A., & Perdew, G. H. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.01.003 · Cited by 67 · see citing works

Artificial sweetener neohesperidin dihydrochalcone showed antioxidative, anti-inflammatory and anti-apoptosis effects against paraquat-induced liver injury in mice

Shi, Q., Song, X., Fu, J., Su, C., Xia, X., Song, E., & Song, Y. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.003 · Cited by 63 · see citing works

A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota

Rivero‐Gutiérrez, B., Gámez‐Belmonte, R., Suárez, M. D., Lavín, J. L., Aransay, A. M., Olivares, M. M., Martínez‐Augustin, O., de Medina, F. S., & Zarzuelo, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600622 · Cited by 50 · see citing works

The metabolism of saccharin in laboratory animals

Byard, J. L., & Golberg, L. (1973) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(73)90005-9 · Cited by 47 · see citing works

The gut‐liver axis in nonalcoholic fatty liver disease

Vanni, E., & Bugianesi, E. (2009) · Hepatology · doi:10.1002/hep.23036 · Cited by 44 · see citing works

Neohesperidin Dihydrochalcone versus CCl4-Induced Hepatic Injury through Different Mechanisms: The Implication of Free Radical Scavenging and Nrf2 Activation

Su, C., Xia, X., Shi, Q., Song, X., Fu, J., Xiao, C., Chen, H., Lu, B., Sun, Z., Wu, S., et al. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b01750 · Cited by 44 · see citing works

Flos Lonicera Combined with Metformin Ameliorates Hepatosteatosis and Glucose Intolerance in Association with Gut Microbiota Modulation

Shin, N. R., Bose, S., Wang, J., Ansari, A., Lim, S.-K., Chin, Y., Choi, H., & Kim, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02271 · Cited by 39 · see citing works

New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer

Ezzaidi, N., Zhang, X., Coker, O. O., & Yu, J. Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.114425 · Cited by 38 · see citing works

Quantitative proteomics reveals systematic dysregulations of liver protein metabolism in sucralose-treated mice

Liu, C., Chi, L., Tu, P., Xue, J., Ru, H., & Lü, K. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.01.011 · Cited by 31 · see citing works

Core Fucosylation of Intestinal Epithelial Cells Protects Against Salmonella Typhi Infection via Up-Regulating the Biological Antagonism of Intestinal Microbiota

Hao, S., Fan, Q., Bai, Y., Fang, H., Zhou, J., Fukuda, T., Gu, J., Li, M., & Li, W. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01097 · Cited by 26 · see citing works

Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway

Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 347 · see citing works

Akkermansia muciniphila : A promising probiotic against inflammation and metabolic disorders

Zhao, Y., Yang, H., Wu, P., Yang, S., Xue, W., Xu, B., Zhang, S., Tang, B., & Xu, D. (2024) · Virulence · doi:10.1080/21505594.2024.2375555 · Cited by 152 · see citing works

<i>Akkermansia muciniphila</i> alleviates <scp>high‐fat‐diet</scp> ‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids

Wu, W., Kaicen, W., Bian, X., Yang, L., Ding, S., Li, Y., Li, S., Zhuge, A., & Li, L. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14293 · Cited by 129 · see citing works

Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis

Li, H., Huang, S., Zhou, D.-D., Xiong, R.-G., Luo, M., Saimaiti, A., Han, M.-K., Gan, R., Zhu, H., & Li, H. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.008 · Cited by 122 · see citing works

Effects of ultra-processed foods on the microbiota-gut-brain axis: The bread-and-butter issue

Song, Z., Song, R., Liu, Y., Wu, Z., & Zhang, X. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112730 · Cited by 132 · see citing works

Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases

Niu, H., Zhou, M., Zogona, D., Xing, Z., Wu, T., Chen, R., Cui, D., Liang, F., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370658 · Cited by 104 · see citing works

Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease

Long, Q., Luo, F., Li, B., Li, Z., Guo, Z., Chen, Z., Wu, W., & Hu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000310 · Cited by 94 · see citing works

Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer

Zhang, L., Ji, Q., Chen, Q., Wei, Z., Liu, S., Zhang, L., Zhang, Y., Li, Z., Liu, H., & Sui, H. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85712 · Cited by 78 · see citing works

Polyphenols as Drivers of a Homeostatic Gut Microecology and Immuno-Metabolic Traits of Akkermansia muciniphila: From Mouse to Man

Rodríguez-Daza, M.-C., & de Vos, W. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010045 · Cited by 81 · see citing works

Function of Akkermansia muciniphila in type 2 diabetes and related diseases

Li, J., Yang, G., Zhang, Q., Liu, Z., Jiang, X. M., & Xin, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1172400 · Cited by 71 · see citing works

Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice

Hou, D., Tang, J., Huan, M., Liu, F., Zhou, S., & Shen, Q. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.04.023 · Cited by 61 · see citing works

Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma

Wu, X., Fan, Y., Chung, K. P. S., Leung, C. O. N., Leung, R. W. H., So, K. K. H., Lei, M. M. L., Chau, W. K., Tong, M., Yu, J. Q., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101900 · Cited by 61 · see citing works

Role of macrophage AHR/TLR4/STAT3 signaling axis in the colitis induced by non-canonical AHR ligand aflatoxin B1

Zhang, L., Cheng, D., Zhang, J., Tang, H., Li, F., Peng, Y., Duan, X., Meng, E., Zhang, C., Zeng, T., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131262 · Cited by 53 · see citing works

Dose-Dependent Beneficial Effects of Tryptophan and Its Derived Metabolites on Akkermansia In Vitro: A Preliminary Prospective Study

Yin, J., Song, Y., Hu, Y., Wang, Y., Zhang, B., Wang, J., Ji, X., & Wang, S. (2021) · Microorganisms · doi:10.3390/microorganisms9071511 · Cited by 52 · see citing works

Structural Insights into Amelioration Effects of Quercetin and Its Glycoside Derivatives on NAFLD in Mice by Modulating the Gut Microbiota and Host Metabolism

Shi, Z., Zhang, C., Lei, H., Chen, C., Cao, Z., Song, Y., Chen, G., Wu, F., Zhou, J., Lu, Y., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06212 · Cited by 50 · see citing works

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease

Gebru, Y., Gupta, H., Kim, H. S., Eom, J. A., Kwon, G., Park, E., Jeong, J.-J., Won, S., Sharma, S., Ganesan, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212190 · Cited by 30 · see citing works

Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

Han, Y., Li, L., & Wang, B. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0960-z · Cited by 41 · see citing works

Early gut microbiota intervention in premature infants: Application perspectives

Xiang, Q., Yan, X., Shi, W., Li, H., & Zhou, K. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.11.004 · Cited by 43 · see citing works

Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice

Wang, M., Li, L., Qian, J., Wang, N., Bao, J., Lu, J., Chen, F., Li, Y., Zhang, Y., & Yan, F. (2023) · iScience · doi:10.1016/j.isci.2023.106346 · Cited by 38 · see citing works

Dietary Isoquercetin Reduces Hepatic Cholesterol and Triglyceride in NAFLD Mice by Modulating Bile Acid Metabolism via Intestinal FXR-FGF15 Signaling

Zhang, C., Shi, Z., Lei, H., Wu, F., Chen, C., Cao, Z., Song, Y., Zhang, C., Zhou, J., Lu, Y., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00952 · Cited by 36 · see citing works

A Critical Review on Akkermansia muciniphila: Functional Mechanisms, Technological Challenges, and Safety Issues

Abbasi, A., Bazzaz, S., da Cruz, A. G., Khorshidian, N., Saadat, Y. R., Sabahi, S., Ozma, M. A., Lahouty, M., Aslani, R., & Mortazavian, A. M. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10118-x · Cited by 37 · see citing works

Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease

Wang, S., Yin, J., Liu, Z., Liu, X., Tian, G., Xin, X., Qin, Y., & Feng, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123211 · Cited by 39 · see citing works

Proteomics and metabolic phenotyping define principal roles for the aryl hydrocarbon receptor in mouse liver

Jin, J., Wahlang, B., Thapa, M., Head, K. Z., Hardesty, J., Srivastava, S., Merchant, M. L., Rai, S. N., Prough, R. A., & Cave, M. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.014 · Cited by 35 · see citing works

Gut Microbiota Regulation of AHR Signaling in Liver Disease

Wang, B., Zhou, Z., & Li, L. (2022) · Biomolecules · doi:10.3390/biom12091244 · Cited by 32 · see citing works

Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions

Zhao, Q., Wu, J., Ding, Y., Pang, Y., & Jiang, C. (2023) · Life Metabolism · doi:10.1093/lifemeta/load032 · Cited by 31 · see citing works

Akkermansia muciniphila Ameliorates Alcoholic Liver Disease in Experimental Mice by Regulating Serum Metabolism and Improving Gut Dysbiosis

Fang, C., Cheng, J., Jia, W. P., & Xu, Y. (2023) · Metabolites · doi:10.3390/metabo13101057 · Cited by 30 · see citing works

Akkermansia muciniphila Enhances Egg Quality and the Lipid Profile of Egg Yolk by Improving Lipid Metabolism

Wei, F., Yang, X., Zhang, M., Xu, C., Hu, Y., & Liu, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.927245 · Cited by 34 · see citing works

Gut Microbiota Manipulation to Mitigate the Detrimental Effects of Environmental Pollutants

Chen, L. (2021) · Toxics · doi:10.3390/toxics9060127 · Cited by 26 · see citing works

Research progress on extraction technology and biomedical function of natural sugar substitutes

Lei, P., Chen, H., Ma, J., Fang, Y., Qu, L., Yang, Q., Peng, B., Zhang, X., Jin, L., & Sun, D. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.952147 · Cited by 23 · see citing works

Re‐evaluation of saccharin and its sodium, potassium and calcium salts (E 954) as food additives

(FAF), E. P. O. F. A. A. F., Castle, L., Andreassen, M., Aquilina, G., Bastos, M. D. L., Boon, P., Fallico, B., FitzGerald, R., Fernández, M. J. F., Grasl‐Kraupp, B., et al. (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.9044 · Cited by 24 · see citing works

Interplay between gut microbiota and tryptophan metabolism in type 2 diabetic mice treated with metformin

Xie, Y.-H., Li, X., Meng, Q., Li, J., Wang, X., Zhu, L., Wang, W., & Li, X. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00291-24 · Cited by 21 · see citing works

Re‐evaluation of neohesperidine dihydrochalcone (E 959) as a food additive

(FAF), E. P. O. F. A. A. F., Younes, M., Aquilina, G., Castle, L., Degen, G. H., Engel, K., Fowler, P. J., Fernández, M. J. F., Fürst, P., Gundert‐Remy, U., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7595 · Cited by 20 · see citing works

Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease

Liu, H., Xu, J., Li, H., Zhang, L., & Xu, P. (2021) · The Anatomical Record · doi:10.1002/ar.24770 · Cited by 18 · see citing works

Perillartine protects against metabolic associated fatty liver in high-fat diet-induced obese mice

Xiao, Y., Xiao, L., Li, M., Liu, S., Wang, Y., Huang, L., Liu, S., Jiang, T., Zhou, L., & Li, Y. (2022) · Food & Function · doi:10.1039/d2fo02227c · Cited by 23 · see citing works

Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation

Liu, A., Huang, M., Xi, Y., Deng, X., & Xu, K. (2025) · Biomedicines · doi:10.3390/biomedicines13061422 · Cited by 17 · see citing works

Swainsonine Induces Liver Inflammation in Mice via Disturbance of Gut Microbiota and Bile Acid Metabolism

Fu, K., Chen, X., Shou, N., Wang, Z., Yuan, X., Wu, D., Wang, Q., Cheng, Y., Ling, N., & Shi, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08519 · Cited by 19 · see citing works

Increased intestinal permeability and lipopolysaccharide contribute to swainsonine-induced systemic inflammation

Lei, L., Deng, D., Xu, W., Yue, M., Wu, D., Fu, K., & Shi, Z. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116912 · Cited by 16 · see citing works

Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics

Pandey, H., Goel, P., Srinivasan, V. M., Tang, D. W. T., Wong, S. H., & Lal, D. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i6.106849 · Cited by 17 · see citing works

Food supply toxicants and additives alter the gut microbiota and risk of metabolic disease

Barra, N. G., Fang, H., Bhatwa, A., Schmidt, A., Syed, S. A., Steinberg, G. R., Morrison, K. M., Surette, M. G., Wade, M. G., Holloway, A. C., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00364.2024 · Cited by 13 · see citing works

Next-generation probiotics

Barbosa, J. C., Machado, D., Almeida, D., Andrade, J. C., Brandelli, A., Gomes, A., & Freitas, A. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85170-1.00012-9 · Cited by 13 · see citing works

Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease

Liang, T., Li, D., Zunong, J., Li, M., Amaerjiang, N., Xiao, H., Khattab, N. M., Vermund, S. H., & Hu, Y. (2022) · Nutrients · doi:10.3390/nu14214641 · Cited by 13 · see citing works

Gut microbiota manipulation to mitigate the toxicities of environmental pollutants

Chen, L., Ahmad, M., Li, J., Li, J., Yang, Z., & Hu, C. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2025.107425 · Cited by 12 · see citing works

Disrupting the Gut–Brain Axis: How Artificial Sweeteners Rewire Microbiota and Reward Pathways

Coccurello, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010220 · Cited by 12 · see citing works

The Function of Xenobiotic Receptors in Metabolic Diseases

Zhang, J., Jia, Q., Li, Y., & He, J. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000862 · Cited by 11 · see citing works

Akkermansia muciniphila alleviates metabolic disorders through gut microbiota-mediated tryptophan regulation

Zhang, F. X., Tian, J., Li, J., Zhang, T., & Wang, X. (2025) · AMB Express · doi:10.1186/s13568-025-01986-3 · Cited by 10 · see citing works

Microbiota-derived indole acetic acid extends lifespan through the AhR-Sirt2 pathway in Drosophila

Cao, Z., Zhang, C., Liu, L., Lei, H., Zhang, H., He, Y., Li, X., Xiang, Q., Wang, Y., Zhang, L., et al. (2025) · mSystems · doi:10.1128/msystems.01665-24 · Cited by 10 · see citing works

Akkermansia muciniphila - A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease

Banerjee, G., Papri, S. R., Satapathy, S. K., & Banerjee, P. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201025666230915103052 · Cited by 10 · see citing works

Sucralose triggers insulin resistance leading to follicular dysplasia in mice

Yang, L., Wang, S., Jin, J., Wang, J., Chen, W., Xue, Y., Sheng, L., Zhai, Y., & Yao, W. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108644 · Cited by 9 · see citing works

Re‐evaluation of sucralose (E 955) as a food additive and evaluation of a new application on extension of use of sucralose (E 955) in fine bakery wares

(FAF), E. P. O. F. A. A. F., Castle, L., Andreassen, M., Aquilina, G., Bastos, M. D. L., Boon, P., Fallico, B., Fitzgerald, R. B., Fernandez, M. J. F., Grasl‐Kraupp, B., et al. (2026) · EFSA Journal · doi:10.2903/j.efsa.2026.9854 · Cited by 9 · see citing works

Effects of Thyroid Powder on Tadpole (Lithobates catesbeiana) Metamorphosis and Growth: The Role of Lipid Metabolism and Gut Microbiota

Zhu, B., Shao, C., Xu, W., Dai, J., Fu, G., & Hu, Y. (2024) · Animals · doi:10.3390/ani14020208 · Cited by 9 · see citing works

Long-Term Triclocarban Exposure Induced Enterotoxicity by Triggering Intestinal AhR-Mediated Inflammation and Disrupting Microbial Community in Mice

Song, Y., Lei, H., Cao, Z., Zhang, C., Chen, C., Wu, M., Zhang, H., Du, R., Lijun, L., Chen, X., et al. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00042 · Cited by 8 · see citing works

Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila

Xu, J., Lao, Y., Zhang, W., Chen, L., Zhang, H., Liu, H., Yan, T., Huang, R., Xu, Y., Ye, L., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110069 · Cited by 7 · see citing works

Combination of GLP-1 receptor agonist and Akkermansia muciniphila Akk11 reduces adiposity and ameliorates MASLD in T2D mice

Gao, K., Yin, Z., Zhang, C., Dong, Z., Wang, R., Chen, Q., Liu, X., Jiang, C., Wang, Y., Guo, B., et al. (2026) · Cell & Bioscience · doi:10.1186/s13578-025-01525-4 · Cited by 7 · see citing works

Isomalt attenuates hepatic steatosis in rats via modulating gut microbiota and its metabolic function

Yang, Z., Su, H., Chen, X., Ni, Z., Tao, H., Jiang, Y., & Peng, L. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105963 · Cited by 6 · see citing works

The association between the health of the intestines and the human body with Akkermansia muciniphila

Tabatabaei, S. A. S., Ghadim, H. Y., Alaei, S., Abdolvand, F., Mazaheri, H., Shamsi, F., SarveAhrabi, Y., & Behrouzi, A. (2025) · The Microbe · doi:10.1016/j.microb.2025.100352 · Cited by 5 · see citing works

The Interplay Between Environmental Pollutants, Gut Microbiota, and Infections

El‐Mansoury, B., Smimih, K., Hamdan, Y. A., Khiat, A. E., Elouali, S., Fatimi, H. E., Draoui, A., Hiba, O. E., & Jayakumar, A. R. (2023) · Advances in human services and public health (AHSPH) book series · doi:10.4018/978-1-7998-9414-8.ch008 · Cited by 5 · see citing works

Anti-Dyslipidemic, Anti-Hypertensive, and Glycemic Control Effects of Akkermansia Muciniphila: Lesser-Known Benefits in Metabolic Syndrome – A Narrative Review

Abolhassani, A., Moghadasian, M. H., Sedaghatnezhad, N., & Jafarnejad, S. (2025) · Heart and Mind · doi:10.4103/hm.hm-d-24-00161 · Cited by 4 · see citing works

Impact of D-allulose consumption on Enteric pathogens in human gut Microbiota: A randomized controlled trial study

Park, H., Baek, J., Park, S. Y., Sa, S., Jun, J. E., Kim, M. J., Jeong, I.-K., & Kim, W. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106555 · Cited by 4 · see citing works

The impact of artificial sweeteners on bacterial physiology and the microbiome

Staber, C., Krawiel, D., & McCarthy, R. R. (2026) · Trends in Microbiology · doi:10.1016/j.tim.2026.01.010 · Cited by 3 · see citing works

Microbial reprogramming of the gut-liver nexus in MASLD: Lessons from Akkermansia muciniphila

Liu, Y., Targher, G., Byrne, C. D., Jiang, C., Tan, Z., Tilg, H., Yu, J., He, Z., Yin, Y., Zheng, M., et al. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100031 · Cited by 3 · see citing works

Faecal Untargeted Metabolomics Analysis Elucidates the Antihyperglycaemic Effect of Surfactin in High-Fat Diet/Streptozotocin-Induced Type 2 Diabetic Mice

Chen, X., Huang, J., Zhao, H., Lu, Y., Meng, F., Lu, Z., Lu, Z., & Lu, Y. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00499-z · Cited by 3 · see citing works

Acalabrutinib alleviates metabolic dysfunction–associated steatotic liver disease by regulating bile acid metabolism

Wang, Y., Chen, S., Ye, B., Yang, Z., Liu, Y., Lou, G., Zhou, C., & Zheng, M. (2025) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2025.106786 · Cited by 3 · see citing works

Industrial production of natural low-calorie sweetener neohesperidin dihydrochalcone

Zhu, X., Liu, W., Liu, Y., Chu, H., Cheng, J., Gao, Y., Liu, J., Shao, X., Xue, M., Ahmed, N., et al. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100190 · Cited by 2 · see citing works

Impaired Indole Acetic Acid and Reduced Indole-Producing Bacteria Contribute to Swainsonine-Induced Liver Inflammation

Fu, K., Shou, N., Yuan, X., Xu, W., Wu, D., Wang, Q., Gu, L., Zeng, Y., Li, Y., & Shi, Z. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c02243 · Cited by 2 · see citing works

Akkermansia muciniphila: A Promising Next Generation Probiotic

Hasnain, M. A., & Moon, G. (2025) · Current Topic in Lactic Acid Bacteria and Probiotics · doi:10.35732/ctlabp.2025.11.1.1 · Cited by 1 · see citing works

Sucralose and the Gut–Immune Axis: Emerging Evidence Linking Dysbiosis, Barrier Alterations, and Implications for Colitis and Colorectal Cancer Immunotherapy

Mejía-Muñoz, A., Monter, J. C., Saldívar-Cerón, H. I., Escobedo, G., & León‐Cabrera, S. (2026) · Biomedicines · doi:10.3390/biomedicines14040917 · Cited by 1 · see citing works

Mechanism and application of Akkermansia muciniphila in inflammatory diseases

Xie, L., Lu, J., Han, H., Liu, Z., Dong, C., Wu, H., & Qiao, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1819005 · Cited by 1 · see citing works

Associations between post-bariatric surgery gut microbiota changes and type 2 diabetes remission: a narrative review

Li, G., Du, Y., Huang, X., Luo, R., Zhou, H., & Song, K. (2026) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2026.07.013 · Cited by 1 · see citing works

Artificial Sweeteners and Host Response Variability: Insights From the Gut Microbiota for Precise Application

Cai, J., Wu, Q., Bekhit, A. E. A., Wang, J., Li, Y., Huang, R., Zhang, F., Xiao, H., Zhu, Z., & Ding, Y. (2026) · Engineering · doi:10.1016/j.eng.2026.05.004

Association of artificial sweeteners intake and risk of CKD: a prospective cohort study

Wang, J., Wang, A., Liu, B., Cao, Y., Sun, T., Zhang, X., Lin, L., Huang, X., Liu, W., Yang, W., et al. (2026) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2026.100917

Meta-analysis reveals a distinct and uniform gut microbial signature associated with endocrine-disrupting chemicals-induced diabetes in rodent models

Durairaj, K., Gajendhran, B., Manivel, G., Gnanam, H., Swaminathan, K., Gilles, M., & Velmurugan, G. (2026) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2026.101677

Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease

Shi, Z., Chen, G., Cao, Z., Wu, F., Lei, H., Chen, C., Song, Y., Liu, C., Li, J., Zhou, J., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07467 · Cited by 47 · see citing works

GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes

Qiu, S., Chen, J., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Nutrients · doi:10.3390/nu14132749 · Cited by 28 · see citing works

Modulation of native decellularized liver matrix enhances hepatic cells proliferation, viability and functions on 3D-bioscaffolds

Gupta, A., Tripathi, D. M., Kaur, S., Rawal, P., Rohilla, S., & Sarin, S. K. (2020) · Journal of Hepatology · doi:10.1016/s0168-8278(20)30989-2

Gut Akkermansia muciniphila ameliorates non-alcoholic fatty liver disease by L-aspartate via interaction with liverPreprint

Rao, Y., Kuang, Z., Li, C., Guo, S., Xu, Y., Zhao, D., Hu, Y., Song, B., Jiang, Z. D., Ge, Z., et al. (2020) · doi:10.22541/au.160225760.01320126/v1 · Cited by 1 · see citing works

Role of short-chain fatty acids in non-alcoholic fatty liver disease and potential therapeutic targets

Qin, X., Chen, M., He, B., Chen, Y., & Zheng, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1539972 · Cited by 26 · see citing works